Atlas Trials

Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife

Clinical trial NCT02363218 · UNKNOWN

Trial details

NCT number
NCT02363218
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Neoplasms
Start date
2014-05-01
Primary completion
2017-05-01
Enrollment
117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.